CARACO PHARMACEUTICAL LABORATORIES LTD - FORM 10-Q - EX-32.1 - EXHIBIT 32.1 - November 9, 2009

Attached files

file filename
10-Q - CARACO PHARMACEUTICALS 10-Q 9-30-2009 - CARACO PHARMACEUTICAL LABORATORIES LTDform10q.htm
EX-3.02 - EXHIBIT 3.02 - CARACO PHARMACEUTICAL LABORATORIES LTDex3_02.htm
EX-31.2 - EXHIBIT 31.2 - CARACO PHARMACEUTICAL LABORATORIES LTDex31_2.htm
EX-2.01 - EXHIBIT 2.01 - CARACO PHARMACEUTICAL LABORATORIES LTDex2_01.htm
EX-31.1 - EXHIBIT 31.1 - CARACO PHARMACEUTICAL LABORATORIES LTDex31_1.htm
EX-10.26 - EXHIBIT 10.26 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_26.htm
EX-10.30 - EXHIBIT 10.30 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_30.htm
EX-10.32 - EXHIBIT 10.32 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_32.htm
EX-10.28 - EXHIBIT 10.28 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_28.htm
EX-10.24 - EXHIBIT 10.24 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_24.htm
EX-10.25 - EXHIBIT 10.25 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_25.htm
EX-10.29 - EXHIBIT 10.29 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_29.htm
EX-10.27 - EXHIBIT 10.27 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_27.htm
EX-3.01 - EXHIBIT 3.01 - CARACO PHARMACEUTICAL LABORATORIES LTDex3_01.htm
EX-10.31 - EXHIBIT 10.31 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_31.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report on Form 10-Q of Caraco Pharmaceutical Laboratories, Ltd. (“Caraco”) for the period ended September 30, 2009 (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of their respective knowledge and belief, that:

(1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Caraco.

 
/s/ Jitendra N. Doshi
  
 
Jitendra N. Doshi
 
Chief Executive Officer
   
 
/s/ Mukul Rathi
  
 
Mukul Rathi
 
interim Chief Financial Officer

November 9, 2009
 
  

CARACO PHARMACEUTICAL LABORATORIES LTD Reports